This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Kymab Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Uwe Platzbecker: Innovator in Sclerosing Disease Treatment
Introduction
Uwe Platzbecker is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of sclerosing diseases. His innovative work has the potential to impact many lives.
Latest Patents
Uwe Platzbecker holds a patent for the "Use of the extracellular domain of transferrin receptor 2 for the diagnosis and treatment of primary or secondary sclerosing diseases." This invention relates to a protein that can be utilized in diagnosing and treating these diseases. It includes a fusion protein, nucleotide sequence, vector, and a pharmaceutical composition aimed at improving patient outcomes.
Career Highlights
Uwe Platzbecker is associated with Kymab Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and excellence in the medical field.
Collaborations
He collaborates with talented individuals such as Martina Rauner and Lorenz C Hofbauer, contributing to a dynamic research environment that fosters creativity and scientific advancement.
Conclusion
Uwe Platzbecker's contributions to the diagnosis and treatment of sclerosing diseases exemplify the impact of innovative thinking in medicine. His work not only enhances scientific knowledge but also holds promise for improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile